Bridgeway Capital Management’s Boston Scientific BSX Stock Holding History

Bridgeway Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,300	Closed	-$1.28M	–	1213
2024 Q3	$1.28M	Hold	15,300	–	–	0.03%	618
2024 Q2	$1.18M	Sell	15,300 -38,000	-71%	-$2.78M	0.03%	642
2024 Q1	$3.65M	Hold	53,300	–	–	0.07%	384
2023 Q4	$3.08M	Sell	53,300 -2,600	-5%	-$139K	0.07%	446
2023 Q3	$2.95M	Buy	+55,900	New	+$2.93M	0.07%	422
2019 Q3	–	Sell	-993,900	Closed	-$42.7M	–	1318
2019 Q2	$42.7M	Buy	993,900 +226,550	+30%	+$8.71M	0.55%	65
2019 Q1	$29.5M	Buy	+767,350	New	+$29.3M	0.37%	83
2014 Q4	–	Sell	-237,300	Closed	-$2.8M	–	1459
2014 Q3	$2.8M	Sell	237,300 -21,900	-8%	-$276K	0.07%	359
2014 Q2	$3.31M	Hold	259,200	–	–	0.09%	312
2014 Q1	$3.5M	Hold	259,200	–	–	0.1%	257
2013 Q4	$3.12M	Hold	259,200	–	–	0.09%	283
2013 Q3	$3.04M	Buy	+259,200	New	+$2.8M	0.1%	219

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bridgeway Capital Management's BSX Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 15,300 shares — an estimated $1.28M sold.

Bridgeway Capital Management first reported a position in BSX in Q3 2013 and held it in 12 quarters. The position peaked at $42.7M in Q2 2019. 1,521 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

Bridgeway Capital Management reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
Bridgeway Capital Management sold 15,300 Boston Scientific shares in Q4 2024, an estimated $1.28M.
Bridgeway Capital Management first reported a position in Boston Scientific in Q3 2013 and held it in 12 quarters.
Bridgeway Capital Management's Boston Scientific position peaked at $42.7M in Q2 2019.
1,521 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.